INSTRUCTION FOR AUTHORS
As a science and technological journal, the Journal of Medical Bioscience (JMBS) aims to publicize biomedical science and relevant academic matters. We are interested in publishing original research and other articles, providing members with the benefits of knowledge, modern experiences, and professional standards.
It is obligatory that articles accepted for publication in this journal have not been previously published in any journals. We recruit peer reviewers from multicentered national standard universities. Each article receives exclusive evaluation by at least 2 specialized peer reviewers per each article with the double-blinded procedure which means that peer reviewers will not know whom they are evaluating and the author will not know the reviewers' names, enhancing the transparency of the process. From the previous process, every submitted article was kept secret and prohibited from commercialization at all means. If any conflicts of interest arise with the reviewer and the author or the subject, the editor would find the substitute review for that article or subject. The submitted manuscript will be destroyed after the evaluation is complete.
JMBS currently publishes two issues per year (semiannually). The first issue covers January to June, while the second issue covers July to December.
Starting in 2027, JMBS will transition to publishing four issues per year (quarterly), as follows:
No. 1: January–March
No. 2: April–June
No. 3: July–September
No. 4: October–December
General criteria and suggestions for article submission
Article types
Original Articles
Average length: 12 pages or 3,000 words
Elements: introduction, methods, materials, results, discussion, conclusion, acknowledgements, references, keywords
Special Articles
Articles originate from experiences or sharing an opinion
Case Report
Prefer both detailed and brief types. Include abstract, case report, clinical and laboratory appraisal, commentary, and summary
Innovations
Thoroughly explained information of the innovation in the original article format. For instance, components, pros and cons, and trial experiments
Review Articles
Illustrate new contents, findings, or interesting issues for further applications. For example, analysis of diseases or pandemic situation responses. Include abstract, objective, content, appraisal, conclusion, and references
Journal Abstracts
Review of newly published international or national journals within 1 year of publication. Include evaluation from the author
Elements of the articles
Title short, brief, and covered
Author Full name with name title
Content elaborating through the objectives with brief
Abstract including only crucial contents of the article within 250 words or 15 lines. Structured abstract should be divided into the following sections:
• Background
• Objectives
• Methods
• Results
• Conclusion
Keyword approximately 3-5 words applying article search
Manuscript
1 page with 1 column manuscript. 21.6 x 29.7 cm or A4 size. Page numbers on the top right of the page. Including illustrations, tables, and submission letters.
The author must submit the manuscript (.doc) online via “https://www.tci-thaijo.org/.index.php/clmb/.index”
Illustration
The illustration must be in black-and-white line art. Write the arrow to orientate the direction of the figure and description in English on the figure. Number Illustrations in the order in which they are cited in the text, and provide a descriptive title for each Illustration on the back. Radiological images must delete the name of the patient.
Table
Number tables in the order in which they are cited in the text, and provide a descriptive title for each table.
References
List the references in consecutive, numerical order, as they are cited in the text. Use Vancouver reference style. If the list of authors exceeds 6, the first 6 authors followed by et al should be listed for those references.
Citing from a journal: Author. Title of the article. Title of the journal Year;Volume:First page–Last Page.
Example: Techanitisawad P, Kittikowit W, Sasiwimonphan K. Differentiation of papillary renal cell carcinoma subtypes by imaging features of CT scan. Chula Med J 2016;60:467-76.
Citing from a book: Author. Title of the book. Edition. Place of publication:Publisher;Year.
Example Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th ed. London: Blackwell; 1993.
Citing from a chapter of a book: Author. Title of a chapter. In: editor(s). Title of the book. Edition. Place of publication: Publisher; Year. p. First page–Last page. Example Hewlett EL. Microbial virulence factors. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious disease. 3rd ed. New York: Churchill Livingstone; 1990. p. 2–9.
Citing from thesis: Author. Title [type/degree]. Place of publication: University; Graduation year.
Example: Kaplan SJ. Post-hospital home health care: the elderly’s access and utilization [dissertation]. St. Louis, MO: Washington University; 1995.
Citing from Journal article on the Internet: Author. Title of the article). Title of the journal [type of media]. Year [cited year month date]; Volume: [First page-Last page]. Available from: https://………..
Example: Annas GJ. Resurrection of a stem-cell funding barrier-Dickey-Wicker in count. N Engl J Med [Internet]. 2010 [cited 2011 Jun 15];363:1687–9. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMp1010466
Publication
As original papers are approved for publication, JMBS will contact the author for the draft approval and the author must send it back within a specified time
Processing charges
There are no submission fees, publication fees, or page charges for all types of articles. All articles published are open access and freely available online to all readers via our journal website.
Authorship Criteria and Contributions
All listed authors should have seen and approved the final version of the manuscript.
All authors of accepted articles must sign and authorship from affirming that they have met all three of the following criteria for authorship, thereby accepting public responsibility for appropriate portions of the content:
- Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data.
- Drafting the article or revising it critically for important intellectual content.
- Approval of the version to be published and all subsequent versions.
Individuals who do not meet the criteria for authorship but who have made substantial, direct contributions to the work (e.g. purely technical help, writing assistance, general or financial or material support) should be acknowledged in the Acknowledgment section of the manuscript, with a brief description of their contributions. Authors should obtain written permission from anyone they wish to list in the Acknowledgment section.
Conflicts of Interest Statement
Please ensure that the initials of each author listed in your manuscript appear in the Conflicts of interest statement. If no authors have any potential conflict of interest, then it may be sufficient to state “The authors have each completed the International Committee of Medical Journal Editors Form for uniform Disclosure of Potential Conflicts of Interest. No authors have any potential conflict of interest to disclose/None of the authors disclose any potential conflict of interest.
Ethical Policies
Institutional review boards
For investigations involving human participants or data, or human material samples, or animal studies or samples, approval of the appropriate institutional ethics review board (IRB) or ethics committee is required, and such approval must be stated in the Methods section of the manuscript naming the ethics review board/committee and the approval number.
For work involving animals, including vertebrates or any regulated invertebrates, full compliance with local, national, and international regulations is necessary, and the protocols must be reviewed in advance by the relevant IRB for the care and use of laboratory animals. Procedures involving any animals are to be undertaken only with the goal of advancing scientific knowledge and with the explicit approval of an Institutional Animal Care and Use Committee (IACUC) before they begin.
Informed Consent
It is necessary for authors to ensure that the anonymity of patients is carefully protected. The names, initials, hospital or national identity numbers, or dates of birth of patients and research subjects should not be used. Other personal or identifying information should not be used unless it is essential to the clinical message or scientific purpose of the article and the patient (or parent, or legally authorized guardian or representative for minors or incapacitated adults) gives written informed consent for publication. A signed statement of informed consent to publish (in print and online) patient descriptions, photographs, or pedigrees should be obtained from all persons (or parents, or legally authorized guardians or representatives) who can be identified in such written descriptions, photographs, or pedigrees (including by the patients themselves). Even where consent has been given, identifying details should be omitted if they are not essential. All authors are required to follow the International Committee of Medical Journal Editors (ICMJE) requirements on privacy and informed consent from patients and study participants.
Publication Malpractice Statement
Author must not simultaneously submit their manuscripts to author publication if that manuscript is under consideration by any other journals.
Redundant or duplicate publication is a paper that overlaps substantially with one already published in print or electronic media. At the time of manuscript submission, authors must inform the editor about all submission and previous publications that might be regard as redundant or duplicate publication of the same or very similar work. Any such publication must be referred to and referenced in the new paper.
The Editors of Journal of Medical Bioscience adhere to principles of research integrity and aim to avoid any type of scientific misconduct, such as fabrication, falsification, plagiarism, redundant publication, or authorship problems. All submitted manuscripts are checked for potential plagiarism of all types, including patchwork plagiarism and text recycling, using specialist services including those from iThenticate, Crossref, and ProQuest, and are reviewed by an editor responsible for publication integrity.
JMBS follows international standards, guidelines, and flowcharts provided by the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources), the Council for International Organizations of Medical Sciences (CIOMS), the World Association of Medical Editors (WAME) (http://www.wame.org/about/recommendations-on-publicationethics-policie), and the Council of Science Editors (http://www.councilscienceeditors.org/resource-library/editorialpolicies/). We follow the Principles of Transparency and Best Practice in Scholarly Publishing (a joint statement by COPE, the Directory of Open Access Journals [DOAJ], WAME, and the Open Access Scholarly Publishers Association [OASPA]; https://doaj.org/bestpractice).
Copyright and Licensing
All manuscripts submitted for publication must be assigned copyright to JMBS. Reproduction, whether in whole or in part, requires written approval from JMBS. The author is responsible for the content of their articles, except for errors incurred during the printing process. All articles published in the JMBS are under the Creative Commons Attribution (CC-BY-NC-ND) license, which permits others to distribute the work, provided that the article is not altered or used commercially. It is not required to obtain permission to distribute the article but to provide credit for the author and journal.
AI use
JMBS considers artificial intelligence (AI) to include large language models such as Chat GPT, and any other technologies which use machine learning, deep learning, logical reasoning, knowledge representation, planning or navigation, natural-language processing, perception, emergent intelligence, or any other similar or equivalent technologies from time to time. This may include technologies that make automated decisions. We recognize the potential for both benefit and harm to academic literature from the use of AI technologies.
The policy
JMBS will consider content where AI technologies are used. Our approach is one of transparency. Where AI technology has been used this should be clearly described. Editors will consider the suitability of the outlined use. Our approach is in line with organizations including the World Association of Medical Editors (WAME) and the Committee on Publication Ethics (COPE). This policy applies to all authors and contributors submitting content for publication in a JMBS title. It applies to all types of content, including original research, debate, opinion, journalism. It applies to all formats, including, without limitation, all text, audio, video and audio-visual material, abstracts, databases, tables, data, diagrams, photographs and other images or illustrative materials. The same principles apply to the use of AI in peer review comments submitted to journals and any other advice or material sent to us.
Transparent reporting of AI technologies in content submitted to JMBS
We expect authors or others who are creating content to disclose and describe use of AI technologies in (a) any content which is submitted to us, (b) any other work by the authors which underpins or is otherwise connected with the content submitted to us, and (c) any key sources which are cited, to the best of the authors’knowledge.
To ensure transparent declaration of AI, authors should:
1) Include an acknowledgement of AI use in the ‘contributor’ section of written material. If the AI use was in the course of research, a fuller description should be included in the methods section.
2) Transparent declaration includes a description of:
a) What AI technology was used (the name of the technology)
b) Why this AI technology was used (the reason for its use)
c) How the AI technology was used (what the task of the technology was)
d) Consider including a summary of the input, output, and the way in which the AI output was reviewed on the part of the authors as supplementary files or additional information for the editor to review. The editor may ask for more information and/or for information to be added to the content for internal use and/or for publication.
Decision making
JMBS will consider whether the way in which AI was used and declared is reasonable and consistent with its publication policies and practice. Content may be rejected or be subject to post-publication changes on the basis of inadequate declaration or on the particular circumstances of its use.
Authorship
AI technologies will not be accepted as an author(s) of any content submitted to JMBS for publication. JMBS only recognises humans as being capable of authorship since they must be accountable for the work.
Responsibility for content produced or influenced by AI technology
Authors and contributors are responsible for content produced by AI technology in their work. This includes responsibility for accuracy, suitable attribution of sources, and absence of plagiarism.
Detection and screening
We may, on a systematic or case by case basis, use screening tools pre-publication to assist with the identification of content generated (in whole or in part) through AI technologies. We may also use such tools post-publication.
Peer review
If reviewers use AI technology to improve word processing and language, they should declare this when submitting their reports. However, reviewers should preserve the confidentiality of the peer review process by not putting unpublished manuscripts that they are reviewing for JMBS (or information about them) into publicly available AI tools where; the security of the confidential information cannot be guaranteed.
Development in the field of AI is continuous. We will review this policy as necessary, or every six months until further notice. Any proposed significant variation will be discussed with relevant stakeholders according to the degree of change proposed and those likely to be affected.
ORCID iD
JMBS is collecting your ORCID iD so we and the wider community can be confident that you are correctly identified and connected with your publication(s). This will ensure your connection to your full body of work stays with you throughout your career. This journal will collect and display authenticated authors’ and coauthors’ iDs on the OJS profile and article page. ORCID is an independent non-profit organization that provides a persistent identifier – an ORCID iD – that distinguishes you from other researchers and a mechanism for linking your research outputs and activities to your iD. ORCID is integrated into many systems used by publishers, funders, institutions, and other research-related services. Read more in orcid.org.
